No price history available.
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | INRm | 4,716 | 5,345 | 7,791 | 9,412 | 9,398 | 10,787 | 11,597 | 11,597 |
| Operating profit | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | INRm | 128 | 375 | 230 | 409 | 428 | 559 | 793 | 793 |
| EPS reported | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Indo Amines Limited operates as a global manufacturer and supplier, focusing on the development and production of a comprehensive range of chemicals, including fine, specialty, performance, and perfumery chemicals, alongside active pharmaceutical ingredients (APIs). Their fine chemical offerings span a wide variety of compounds such as aliphatic and aromatic amines and nitriles, halides, alcohols (including cycloalkanols and cycloalkanones), various acids and esters, advanced intermediates, amine hydrochlorides, and ethanol amines. In the specialty chemicals category, they provide fatty acids, numerous types of amines (amides, di-amines, tertiary amines, polyamines), amine ethoxylates, and quaternary ammonium compounds. The company's performance chemicals consist of additives like anti-caking, anti-foaming, anti-static, anti-stripping, anti-bacterial/anti-slime, and flotation agents, complemented by granulating aids, defoamers, emulsifiers, curing aids, bitumen emulsifiers, corrosion inhibitors, and demulsifiers. These versatile chemical products are extensively utilized in diverse industries such as pharmaceuticals, agrochemicals, fertilizers, petrochemicals, perfumery, road construction, pesticides, dyes and intermediates, water treatment, oil field operations, mining, paints, pigments, polymers, metalworking and lubricants, various additives, textile processing, cosmetics, and home and personal care applications. Indo Amines Limited was founded in 1992 and is headquartered in Thane, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Indo Amines Limited (INDOAMIN.NS)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Indo Amines Limited operates as a global manufacturer and supplier, focusing on the development and production of a comprehensive range of chemicals, including fine, specialty, performance, and perfumery chemicals, alongside active pharmaceutical ingredients (APIs). Their fine chemical offerings span a wide variety of compounds such as aliphatic and aromatic amines and nitriles, halides, alcohols (including cycloalkanols and cycloalkanones), various acids and esters, advanced intermediates, amine hydrochlorides, and ethanol amines. In the specialty chemicals category, they provide fatty acids, numerous types of amines (amides, di-amines, tertiary amines, polyamines), amine ethoxylates, and quaternary ammonium compounds. The company's performance chemicals consist of additives like anti-caking, anti-foaming, anti-static, anti-stripping, anti-bacterial/anti-slime, and flotation agents, complemented by granulating aids, defoamers, emulsifiers, curing aids, bitumen emulsifiers, corrosion inhibitors, and demulsifiers. These versatile chemical products are extensively utilized in diverse industries such as pharmaceuticals, agrochemicals, fertilizers, petrochemicals, perfumery, road construction, pesticides, dyes and intermediates, water treatment, oil field operations, mining, paints, pigments, polymers, metalworking and lubricants, various additives, textile processing, cosmetics, and home and personal care applications. Indo Amines Limited was founded in 1992 and is headquartered in Thane, India.
